Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter May 6, 2021

The successful inclusion of ADA SCID in Tuscany expanded newborn screening program

  • Sabrina Malvagia , Silvia Funghini , Maria Della Bona , Daniela Ombrone , Massimo Mura , Roberta Damiano , Silvia Ricci , Martina Cortimiglia , Chiara Azzari and Giancarlo la Marca ORCID logo EMAIL logo

Corresponding author: Prof. Giancarlo la Marca, Newborn Screening, Clinical Chemistry and Pharmacology Lab, Meyer Children’s University Hospital, Florence, Italy; and Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Pieraccini 24, 50139, Florence, Italy, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Written informed consent is not required due to the fact that NBS is mandatory by law.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review due to the fact the newborn screening is mandatory by national law (167/2016) and regional law (DGR 909/2018).

References

1. Speckmann, C, Neumann, C, Borte, S, la Marca, G, Sass, JO, Wiech, E, et al.. Delayed-onset adenosine deaminase deficiency: strategies for an early diagnosis. J Allergy Clin Immunol 2012;130:991–4. https://doi.org/10.1016/j.jaci.2012.04.004.Search in Google Scholar PubMed

2. Hershfield, MS, Mitchell, BS. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: Scriver, CR, AL Beaudet, WS S, Valle, D, editors. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill; 1995:1725–68 pp.Search in Google Scholar

3. Verbsky, JW, Baker, MW, Grossman, WJ, Hintermeyer, M, Dasu, T, Bonacci, B, et al.. Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008–2011). J Clin Immunol 2012;32:82–8. https://doi.org/10.1007/s10875-011-9609-4.Search in Google Scholar PubMed

4. Gaspar, HB, Hammarström, L, Mahlaoui, N, Borte, M, Borte, S. The case for mandatory newborn screening for severe combined immunodeficiency (SCID). J Clin Immunol 2014;34:393–7. https://doi.org/10.1007/s10875-014-0029-0.Search in Google Scholar PubMed

5. Chan, K, Davis, J, Pai, SY, Bonilla, FA, Puck, JM, Apkon, M. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metabol 2011;104:383–9. https://doi.org/10.1016/j.ymgme.2011.07.007.Search in Google Scholar PubMed PubMed Central

6. Borte, S, von Döbeln, U, Fasth, A, Wang, N, Janzi, M, Winiarski, J, et al.. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood 2012;119:2552–5. https://doi.org/10.1182/blood-2011-08-371021.Search in Google Scholar PubMed

7. Comeau, AM, Hale, JE, Pai, SY, Bonilla, FA, Notarangelo, LD, Pasternack, MS, et al.. Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency. J Inherit Metab Dis 2010;33:S273–81. https://doi.org/10.1007/s10545-010-9103-9.Search in Google Scholar PubMed

8. Kalman, L, Lindegren, ML, Kobrynski, L, Vogt, R, Hannon, H, Howard, JT, et al.. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genet Med 2004;6:16–26. https://doi.org/10.1097/01.gim.0000105752.80592.a3.Search in Google Scholar

9. Azzari, C, la Marca, G, Resti, M. Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry. J Allergy Clin Immunol 2011;127:1394–9. https://doi.org/10.1016/j.jaci.2011.03.040.Search in Google Scholar PubMed

10. la Marca, G, Canessa, C, Giocaliere, E, Romano, F, Malvagia, S, Funghini, S, et al.. Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots. J Allergy Clin Immunol 2014;134:155–9. https://doi.org/10.1016/j.jaci.2014.01.040.Search in Google Scholar PubMed

11. la Marca, G, Giocaliere, E, Malvagia, S, Funghini, S, Ombrone, D, Della Bona, ML, et al.. The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry. J Pharm Biomed Anal 2014;88:201–6. https://doi.org/10.1016/j.jpba.2013.08.044.Search in Google Scholar PubMed

12. Arredondo-Vega, FX, Santisteban, I, Daniels, S, Toutain, S, Hershfield, MS. Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles. Am J Hum Genet 1998;63:1049–59. https://doi.org/10.1086/302054.Search in Google Scholar PubMed PubMed Central

Received: 2021-03-13
Accepted: 2021-04-22
Published Online: 2021-05-06
Published in Print: 2021-09-27

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 26.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2021-0307/html
Scroll to top button